Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.AEZS
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:AEZS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(153)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Jul 05, 2024 11:38am
A Big Thank you to Proph
I would like to take a moment and thank proph for pointing out all of gagnon's and now NoShowRonnie's failures and missed opportunities. Everytime you post something about the potential of
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jul 04, 2024 11:33am
RE:Perplexity Ai on the potential of a wound healing franchise
Targeting inflammation and fibrosis: The unique mechanism of action discovered for PGX yeast beta glucan in addressing inflammation and fibrosis through macrophage modulation could be a key
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 04, 2024 10:14am
Simply Better Brands
I mentioned Simply Better Brands as a plant based snack company in the last few months as AEZS plans the launch of its beta glucan chewy product with established health claims in the second half of
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 04, 2024 7:14am
Perplexity Ai on the potential of a wound healing franchise
Ceapro could create a promising wound healing franchise by leveraging its research on beta glucan, avenanthramides, PGX technology, and other related areas. Here's how they could potentially
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 04, 2024 6:21am
Wound healing franchise
Gilles called the wound healing results from the Angiogenesis Foundation a "home run" and a possible wound healing franchise has been mentioned. This month will be one year since the
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 03, 2024 8:24pm
Crazy things can happen with a stock with so few shares...
When you take a stock with only about 3.9 million shares outstanding, for sake of argument, that only has a market cap of C$23.25 million and is trading at about 2/3 of its cash and then you unleash a
...more
(46)
•••
Apostata
X
View Profile
View Bullboard History
Post by
Apostata
on Jul 03, 2024 9:58am
Voted
As with the sham merger, I voted NO to all resolutions, as should everyone. Don't be like Oats and get taken advantage of with empty promises for small concessions.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jul 02, 2024 9:02pm
RE:RE:10 days until the AGM
Interesting moment. Are we watching a market failure to recognize value? Market capitalization is about ~$23.5 million with perhaps C$35 million cash. It would seem cheap trading at 67% cash. H.C
...more
(4)
•••
Picker1
X
View Profile
View Bullboard History
Comment by
Picker1
on Jul 02, 2024 5:13pm
RE:10 days until the AGM
And yet the price keeps going down
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 02, 2024 4:09pm
10 days until the AGM
Transformational products demand transformational data, transformational deals and a transformational plan.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 01, 2024 9:38am
Ronnie Miller: "transformational products"
- PGX-YBG 5X more potent - First inhalable product - Blew away industry gold standard in University of Alberta bioavailability study - Potential first-in-class slow release formulations - Potential
...more
(2115)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 30, 2024 7:05pm
RE:RE:RE:RE:RE:SO OATS GUESS WHO IS UP FOR THE NEW BOARD
Gagnon got plenty of no votes at the last AGMs of CZO and AEZS. Let's get rid of him this time.
(153)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Jun 30, 2024 1:18pm
Re; - The questions now ANSWERS
The questions now: 1) Is Ronald Miller well placed to know if AEZS has "transformational products"? NO surprise here as NoSHOWRONNIE was unable to arouse any outside interest in a
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 30, 2024 12:28pm
The questions now:
Ronald W. Miller, Chair of the Company: “With the successful completion of this merger, we are now optimized to bring value-driving, transformational products to the market.” The questions now:
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 30, 2024 10:54am
Biomaterials
Perplexity Ai: "The average time from submission to publication for an article in the journal Biomaterials is around 131 days." It has been 62 days since AEZS said it "recently"
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden